Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker.
Saved in:
| Title: | Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker. |
|---|---|
| Authors: | Luo, Tiancheng1,2,3 (AUTHOR), Peng, Deyou1,2 (AUTHOR), Zhang, Zhouao1 (AUTHOR), Yang, Mingjin1,2,3 (AUTHOR), Guo, Xinyan1,2 (AUTHOR), Ma, Tianyu1,2 (AUTHOR), Huang, Xiaoyu1 (AUTHOR), Xu, Mingming4 (AUTHOR) 2403697215@qq.com, Fu, Linlin5,6 (AUTHOR) 2926263037@qq.com, Zhang, Yong1 (AUTHOR) zy20037416@163.com |
| Source: | Annals of Clinical & Translational Neurology. Apr2026, Vol. 13 Issue 4, p796-806. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
